(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 25.81% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.32%.
Genedx Holdings's revenue in 2026 is $427,539,000.On average, 10 Wall Street analysts forecast WGS's revenue for 2026 to be $16,276,630,924, with the lowest WGS revenue forecast at $15,643,115,500, and the highest WGS revenue forecast at $17,113,117,310. On average, 10 Wall Street analysts forecast WGS's revenue for 2027 to be $20,515,297,233, with the lowest WGS revenue forecast at $18,656,926,743, and the highest WGS revenue forecast at $22,459,190,840.
In 2028, WGS is forecast to generate $24,984,173,029 in revenue, with the lowest revenue forecast at $21,621,825,792 and the highest revenue forecast at $29,318,027,739.